However, most other studies did not find a correlation between elevated levels of IGF-1 and IGFBP-3 with adverse BC outcomes such as all-cause mortality, BC-specific mortality, and recurrence [76,77]. This evidence concerns the gene IGFBP3 and breast cancer.